MCM2 and cancer: The MSIsensor score was much higher in cancers with multiple MCM2 mutations (14.53; 8.90–20.17) than those with missense MCM2 mutations (0.04; 0.07–17.06) and truncating MCM2 mutations (0.03; 0.01–0.05).